0000899243-23-015767.txt : 20230616
0000899243-23-015767.hdr.sgml : 20230616
20230616161535
ACCESSION NUMBER: 0000899243-23-015767
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230616
DATE AS OF CHANGE: 20230616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POWELL MICHAEL
CENTRAL INDEX KEY: 0001202793
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 231021306
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 LIBERTY BLVD.
STREET 2: SUITE 230
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 45 LIBERTY BLVD.
STREET 2: SUITE 230
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-14
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001202793
POWELL MICHAEL
C/O GALERA THERAPEUTICS, INC.
45 LIBERTY BLVD #230
MALVERN
PA
19355
1
0
0
0
0
Stock Option (Right to Buy)
3.27
2023-06-14
4
A
0
64000
0.00
A
2033-06-13
Common Stock
64000
64000
D
This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.
/s/ Christopher Degnan, Attorney-in-Fact for Michael F. Powell
2023-06-16